Anbio Biotechnology (NNNN) Operating income 2022–2025
Anbio Biotechnology (NNNN) annual operating income history from SEC filings — each fiscal year as reported.
$5.8MFY2025 · since FY2022: $10.2M → $5.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.8M | +189.1% |
| FY2024 | $2.0M | +1.8% |
| FY2023 | $2.0M | -80.8% |
| FY2022 | $10.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice